Cargando…

Green tea influence on iron overload in thalassemia intermedia patients: a randomized controlled trial

Background: Although iron chelation therapies have been available for many years for thalassemia intermedia patients, iron accumulation remains the major cause of death. Therefore, the need for additional chelation options is in demand. This randomized controlled study aimed to understand the effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Momen, Hayder, Hussein, Hussein Khudhair, Al-Attar, Zaid, Hussein, Mohammed Jalal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520712/ https://www.ncbi.nlm.nih.gov/pubmed/33024552 http://dx.doi.org/10.12688/f1000research.25553.1

Ejemplares similares

Relationship between liver iron concentration determined by R2-MRI, serum ferritin, and liver enzymes in patients with thalassemia intermedia
por: Al-Momen, Hayder, et al.
Publicado: (2018)

Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients
por: Abdulzahra, Mohammed Saied, et al.
Publicado: (2011)

Endocrine and Bone Complications in β-Thalassemia Intermedia: Current Understanding and Treatment
por: Inati, Adlette, et al.
Publicado: (2015)

Green tea activity and iron overload induced molecular fibrogenesis of rat liver
por: Al-Basher, Gadah I.
Publicado: (2019)

Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion-dependent β-thalassemia
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2017)

Thalassemia Intermedia: Chelator or Not?
por: Lee, Yen-Chien, et al.
Publicado: (2022)

Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq
por: Amin, Shaema Salih, et al.
Publicado: (2020)

Global longitudinal strain as an Indicator of cardiac Iron overload in thalassemia patients
por: Abtahi, Firoozeh, et al.
Publicado: (2019)

β-Thalassemia Intermedia in Northern Iraq: A Single Center Experience
por: Al-Allawi, Nasir A. S., et al.
Publicado: (2014)

Reference ranges for biventricular volumes and ejection fraction and for left ventricular mass in adult thalassemia intermedia patients without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2013)

Corrigendum to “Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq”
por: Amin, Shaema Salih, et al.
Publicado: (2020)

Endocrine Function in Thalassemia Intermedia
por: Karamifar, H., et al.
Publicado: (2006)

Protein C and S levels in patients with Thalassemia intermedia
por: Mohammed, Nawsherwan Sadiq
Publicado: (2022)

Prevalence of iron overload complications among patients with β-thalassemia major treated at Dubai Thalassemia Centre
por: Belhoul, Khawla Mohammed, et al.
Publicado: (2013)

Oxidative Stress (Malondialdehyde) in Adults Beta-Thalassemia Major and Intermedia: Comparison Between Before and After Blood Transfusion and Its Correlation with Iron Overload
por: Atmakusuma, Tubagus Djumhana, et al.
Publicado: (2021)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Did the Proband Have Thalassemia Intermedia or Severe Thalassemia Trait?
por: Özsoylu, Şinasi
Publicado: (2012)

Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia
por: Schmidt, Paul J, et al.
Publicado: (2015)

Renal Dysfunction in Pediatric Patients in Iraq With β-Thalassemia Major and Intermedia
por: Shaalan, Mohammad G, et al.
Publicado: (2022)

Effects of green tea extract treatment on erythropoiesis and iron parameters in iron-overloaded β-thalassemic mice
por: Settakorn, Kornvipa, et al.
Publicado: (2022)

Iron homeostasis in a mouse model of thalassemia intermedia is altered between adolescence and adulthood
por: Sanyear, Chanita, et al.
Publicado: (2020)

Therapeutic potential of silymarin as a natural iron‐chelating agent in β‐thalassemia intermedia
por: Reisi, Nahid, et al.
Publicado: (2022)

P1454: CLINICAL DETERMINANTS OF CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

Jadenu(®) Substituting Exjade(®) in Iron Overloaded β-Thalassemia Major (BTM) Patients: A Preliminary Report of the Effects on the Tolerability, Serum Ferritin Level, Liver Iron Concentration and Biochemical Profiles
por: Yassin, Mohamed A, et al.
Publicado: (2018)

Lack of correlation between non-labile iron parameters, total carbonyl and malondialdehyde in major thalassemia
por: Al-Hakeim, Hussein Kadhem, et al.
Publicado: (2014)

Evaluation of Cardiac Function in Patients with Thalassemia Intermedia
por: Nouri, NM, et al.
Publicado: (2013)

Secondary Haemochromatosis in a Patient with Thalassemia Intermedia
por: ROTARU, IONELA, et al.
Publicado: (2014)

The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study
por: Meloni, Antonella, et al.
Publicado: (2021)

β-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
por: Melchiori, Luca, et al.
Publicado: (2010)

Myocardial iron overload in sickle/thalassemia patients of Italian origin
por: Meloni, Antonella, et al.
Publicado: (2013)

Myocardial iron overload in thalassemia major. How early to check?
por: Meloni, Antonella, et al.
Publicado: (2014)

Treating iron overload in patients with non-transfusion-dependent thalassemia
por: Taher, Ali T, et al.
Publicado: (2013)

Treating thalassemia major-related iron overload: the role of deferiprone
por: Berdoukas, Vasilios, et al.
Publicado: (2012)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea
por: Zekavat, Omid Reza, et al.
Publicado: (2014)

β-Thalassemia Intermedia: A Bird’s-Eye View
por: Haddad, Anthony, et al.
Publicado: (2014)

Echocardiographic evaluation of thalassemia intermedia patients in Duhok, Iraq
por: Mohammad, Ameen Mosa
Publicado: (2014)

Tophaceous gout in thalassemia intermedia: a rare association
por: Mishra, Vikas, et al.
Publicado: (2016)

Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge?
por: Komninaka, Veroniki, et al.
Publicado: (2023)

Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
por: Ghasemi, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7hv31srlrhcqevrjlr016k4t63